Windtree Contracts Chinese Firm to Make Evofem's Contraceptive

Dow Jones

Jun 27, 2025

By Dean Seal

Windtree Therapeutics said it has contracted with a pharmaceutical manufacturer in China to produce Evofem Biosciences's hormone-free contraceptive product Phexxi at a low cost.

The biotechnology company, Evofem's sourcing partner for Phexxi since March, said Thursday that the contract should cut Phexxi's manufacturing costs by over 50% by the end of 2026.

Windtree expects to start seeing some revenue from the arrangement next year.

Early-stage manufacturing is set to begin later this year.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

June 26, 2025 16:57 ET (20:57 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2546519027"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2546519027\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2546519027?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-27 04:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2546519027","market":"sg","top_or_hot":-1,"title":"Windtree Contracts Chinese Firm to Make Evofem's Contraceptive","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Dean Seal \n</p>\n<p>\n  Windtree <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> said it has contracted with a pharmaceutical manufacturer in China to produce Evofem Biosciences's hormone-free contraceptive product Phexxi at a low cost. \n</p>\n<p>\n  The biotechnology company, Evofem's sourcing partner for Phexxi since March, said Thursday that the contract should cut Phexxi's manufacturing costs by over 50% by the end of 2026. \n</p>\n<p>\n  Windtree expects to start seeing some revenue from the arrangement next year. \n</p>\n<p>\n  Early-stage manufacturing is set to begin later this year. \n</p>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 26, 2025 16:57 ET (20:57 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Windtree Contracts Chinese Firm to Make Evofem's Contraceptive</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWindtree Contracts Chinese Firm to Make Evofem's Contraceptive\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-06-27 04:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Dean Seal \n</p>\n<p>\n  Windtree <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> said it has contracted with a pharmaceutical manufacturer in China to produce Evofem Biosciences's hormone-free contraceptive product Phexxi at a low cost. \n</p>\n<p>\n  The biotechnology company, Evofem's sourcing partner for Phexxi since March, said Thursday that the contract should cut Phexxi's manufacturing costs by over 50% by the end of 2026. \n</p>\n<p>\n  Windtree expects to start seeing some revenue from the arrangement next year. \n</p>\n<p>\n  Early-stage manufacturing is set to begin later this year. \n</p>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 26, 2025 16:57 ET (20:57 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"WINT","symbol_name":"Windtree Therapeutics, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2546519027","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2546519027","pubTimestamp":1750971420,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Windtree Therapeutics said it has contracted with a pharmaceutical manufacturer in China to produce Evofem Biosciences's hormone-free contraceptive product Phexxi at a low cost.The biotechnology company, Evofem's sourcing partner for Phexxi since March, said Thursday that the contract should cut Phexxi's manufacturing costs by over 50% by the end of 2026.Windtree expects to start seeing some revenue from the arrangement next year.Early-stage manufacturing is set to begin later this year.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"WINT":"Windtree Therapeutics, Inc.","BK4584":"避孕概念","BK4007":"制药","EVFM":"Evofem Biosciences, Inc.","BK4139":"生物科技"},"translate_title":"Windtree与中国公司签订合同生产Evofem避孕药","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WINT":0.9,"EVFM":0.9},"content_text":"By Dean Seal \n\n\n  Windtree Therapeutics said it has contracted with a pharmaceutical manufacturer in China to produce Evofem Biosciences's hormone-free contraceptive product Phexxi at a low cost. \n\n\n  The biotechnology company, Evofem's sourcing partner for Phexxi since March, said Thursday that the contract should cut Phexxi's manufacturing costs by over 50% by the end of 2026. \n\n\n  Windtree expects to start seeing some revenue from the arrangement next year. \n\n\n  Early-stage manufacturing is set to begin later this year. \n\n\n  Write to Dean Seal at dean.seal@wsj.com \n\n\n  (END) Dow Jones Newswires\n\n\n  June 26, 2025 16:57 ET (20:57 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}